GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » EV-to-Revenue

International Biotechnology Trust (LSE:IBT) EV-to-Revenue : 12.44 (As of May. 25, 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, International Biotechnology Trust's enterprise value is £248.13 Mil. International Biotechnology Trust's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was £19.95 Mil. Therefore, International Biotechnology Trust's EV-to-Revenue for today is 12.44.

The historical rank and industry rank for International Biotechnology Trust's EV-to-Revenue or its related term are showing as below:

LSE:IBT' s EV-to-Revenue Range Over the Past 10 Years
Min: -41.98   Med: 4.62   Max: 36.5
Current: 12.44

During the past 13 years, the highest EV-to-Revenue of International Biotechnology Trust was 36.50. The lowest was -41.98. And the median was 4.62.

LSE:IBT's EV-to-Revenue is ranked worse than
59.97% of 1454 companies
in the Asset Management industry
Industry Median: 9.68 vs LSE:IBT: 12.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), International Biotechnology Trust's stock price is £6.12. International Biotechnology Trust's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was £0.52. Therefore, International Biotechnology Trust's PS Ratio for today is 11.72.


International Biotechnology Trust EV-to-Revenue Historical Data

The historical data trend for International Biotechnology Trust's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust EV-to-Revenue Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.67 5.46 11.06 -14.51 33.63

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -14.51 - 33.63 -

Competitive Comparison of International Biotechnology Trust's EV-to-Revenue

For the Asset Management subindustry, International Biotechnology Trust's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's EV-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's EV-to-Revenue falls into.



International Biotechnology Trust EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

International Biotechnology Trust's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=248.127/19.946
=12.44

International Biotechnology Trust's current Enterprise Value is £248.13 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. International Biotechnology Trust's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was £19.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Biotechnology Trust  (LSE:IBT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

International Biotechnology Trust's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.12/0.522
=11.72

International Biotechnology Trust's share price for today is £6.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Feb. 2024 was £0.52.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Biotechnology Trust EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines